Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of <i>Candida parapsilosis</i> and Elevation of Micafungin MICs in Non-<i>parapsilosis Candida</i> Species
Introduction: Micafungin is a recommended echinocandin antifungal agent for candidemia treatment and prophylaxis. However, overuse of echinocandin antifungals may cause resistance. There is currently no information available regarding the low susceptibility associated with using micafungin. This stu...
Main Authors: | Yasutaka Sakamoto, Kazuhiro Kawabe, Tomoyo Suzuki, Kayoko Sano, Kazuo Ide, Tetsuta Nishigaki, Yuki Enoki, Kazuaki Taguchi, Hirofumi Koike, Hideaki Kato, Yukiko Sahashi, Kazuaki Matsumoto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/7/8/596 |
Similar Items
-
Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
by: Fazal Shirazi, et al.
Published: (2015-10-01) -
A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
by: Yuta Norimatsu, et al.
Published: (2017-06-01) -
Micafungin Is an Efficient Treatment of Multi Drug-Resistant <i>Candida glabrata</i> Urosepsis: A Case Report
by: Zuzana Javorova Rihova, et al.
Published: (2021-09-01) -
Candidemia among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of <i>Candida parapsilosis</i>
by: Rasmus Krøger Hare, et al.
Published: (2022-02-01) -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
by: Mingyue Sun, et al.
Published: (2019-01-01)